Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Munich

CRISPR-Whisper Roadshow in Munich

The CRISPR-Whisper science communication project aims to enhance public understanding of the globally recognized CRISPR-Cas 'gene scissors' technology. This initiative is specifically designed for anyone [...]

Go to Top